Edwin Ostrin MD PhD
Critical Care Medicine, Pleural Disease
Assistant Professor
Join to View Full Profile
1515 Holcombe BlvdUnit 1465Houston, TX 77030
Phone+1 713-792-2340
Dr. Ostrin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Edwin Ostrin is a pulmonologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Baylor College of Medicine and has been in practice 10 years. He specializes in critical care medicine and pleural disease and is experienced in lung cancer, pulmonology, critical care medicine, and internal medicine.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009- Johns Hopkins UniversityInternship, Internal Medicine, 2006 - 2007
Baylor College of MedicineClass of 2006
Baylor College of MedicinePh.D., Molecular and Human Genetics, 2005- University of TexasB.S., Molecular Biology, 1997
Certifications & Licensure
CA State Medical License 2009 - Present
FL State Medical License 2021 - Present
TX State Medical License 2013 - 2027
OK State Medical License 2020 - 2026
WA State Medical License 2024 - 2026
AL State Medical License 2024 - 2025
AZ State Medical License 2024 - 2025
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Publications & Presentations
PubMed
- Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers.Yihui Chen, Riccardo Ballarò, Marta Sans, Fredrik Ivar Thege, Mingxin Zuo
Gut. 2025-04-23 - Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status.Sara Nofal, Edwin J Ostrin, Jianjun Zhang, Jia Wu, Paul Scheet
International Journal of Cancer. 2025-04-18 - Natural history models for lung Cancer: A scoping review.Renu Sara Nargund, Sayaka Ishizawa, Maryam Eghbalizarch, Paul Yeh, Seyyed Mostafa Mousavi Janbeh Saray
Lung Cancer. 2025-03-26
Press Mentions
MD Anderson Secures Nearly $23 Million in CPRIT Grants for Cancer Research and Faculty RecruitmentFebruary 19th, 2025
My Thymoma Treatment: Why I Chose MD AndersonJuly 25th, 2019
Rounding up: Perfecting ICU RoundsMay 22nd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
